Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 EP885 | DOI: 10.1530/endoabs.41.EP885

ECE2016 Eposter Presentations Pituitary - Clinical (83 abstracts)

What is the outcome of nonfunctioning pituitary adenomas (NFPAs) after surgery and are there any factors to predict it: a multicenter study in Northern Spain

Maria Galiana Rodriguez Caballero1, Nuria Valdés Gallego1, Jessica Ares3, Ihintza Larrañaga2, Cecilia Hernández Morhain3, Dolores Ollero2, Sonia Gaztambide3, Leire Isasa3, Lluis Forga2, Marta Mouritz2, Lorena Suárez1, Rosa Rodriguez2, Daniela Corte1, Elías Delgado1, Cecilia Sánchez Ragnarsson1, Lorena Suárez1, Laura Cacho1, Joaquín Pertierra1, Antonio Rabal1 & Edelmiro Menéndez1


1Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain; 2Departament of Endocrinology, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain; 3Department of Endocrinology, Hospital Universitario de Cruces, Bilbao, País Vasco, Spain.


Introduction: There is scarcity of data on the recurrence and/or progression (R/P) rate in nonfunctioning pituitary adenomas (NFPAs) after surgery and the risk factors that can predict this outcome. So the aim of this study was to analyze a large series of NFPAs with a long follow-up after surgery, focusing on the evaluation of R/P rate and the risk factors associated with it.

Methods: Retrospective cohort analysis of 164 patients with NFPAs from 3 different centers in Northern Spain who underwent surgery between 1987–2014. The main outcomes were R/P rate during follow-up using Kaplan-Meier estimator and the univariate and multivariate analysis of risk factors that could be involved with R/P.

Results: R/P was detected in 70 patients (43%) after surgery, over a median clinical follow-up of 8 years (1–27), the median time to R/P was 4.1 years. Recurrence-free survival was 65%, 49%, 42% and 32% at 5, 10, 15 and 20 years after surgery, respectively. The univariate analysis identified the following R/P risk factors: pituitary apoplexy and visual impairment at diagnosis; and as protective factor: RT after surgery in patients with subtotal resection (STR) but the multivariate Cox analysis only confirmed as independent factors: visual impairment (hazard ratio [HR] 2.1, 95% confidence interval [CI] 1.1–4.2; P=0,02) and RT in patients with STR after surgery (HR 0.4, 95% CI 0.21–0.89; P=0.02).

Conclusions: Long term follow-up in NFPAs after surgery is mandatory because R/P occurs in a large percentage of these patients and the risk does not disappear in the long term. Our study suggests that this follow-up has to be more rigorous in patients with visual impairment at diagnosis because they have the highest risk of R/P. RT could decrease this risk specially in those patients with subtotal tumor resection.

Article tools

My recent searches

No recent searches.